Publication: Generation and hematopoietic differentiation of mesenchymal stromal/stem cell-derived induced pluripotent stem cell lines for disease modeling of hematopoietic and immunological diseases
dc.contributor.coauthor | Aerts-Kaya, Fatima | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Esken, Gülen Güney | |
dc.contributor.kuprofile | Other | |
dc.contributor.schoolcollegeinstitute | N/A | |
dc.contributor.yokid | N/A | |
dc.date.accessioned | 2024-11-09T22:48:43Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Here, we describe a protocol for reprogramming of bone marrow–derived multipotent mesenchymal stromal/stem cells to obtain induced pluripotent stem cells from patients with primary immune deficiencies using lentiviral vectors, followed by hematopoietic differentiation of the MSC-derived iPSCs. This protocol is particularly helpful in cases where it is difficult to obtain sufficient numbers of hematopoietic cells for research and can be applied to model any hematological/immunological disease. © 2021, Springer Science+Business Media, LLC. | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.volume | 2549 | |
dc.identifier.doi | 10.1007/7651_2021_452 | |
dc.identifier.issn | 1064-3745 | |
dc.identifier.link | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133525952&doi=10.1007%2f7651_2021_452&partnerID=40&md5=195135b56eac77ced7a5087b905c97e5 | |
dc.identifier.scopus | 2-s2.0-85133525952 | |
dc.identifier.uri | http://dx.doi.org/10.1007/7651_2021_452 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/6373 | |
dc.keywords | Differentiation | |
dc.keywords | Hematopoiesis | |
dc.keywords | Hematopoietic stem cells | |
dc.keywords | Induced pluripotent stem cells | |
dc.keywords | Mesenchymal stem cells antibody | |
dc.keywords | Buffer | |
dc.keywords | Growth factor | |
dc.keywords | Cell differentiation | |
dc.keywords | Coculture | |
dc.keywords | Controlled study | |
dc.keywords | Flow cytometry | |
dc.keywords | Fluorescence activated cell sorting | |
dc.keywords | Freezing | |
dc.keywords | Hematologic disease | |
dc.keywords | Hematopoiesis | |
dc.keywords | Human | |
dc.keywords | Human cell | |
dc.keywords | Human cell culture | |
dc.keywords | Immune deficiency | |
dc.keywords | Immunofluorescence assay | |
dc.keywords | Immunophenotyping | |
dc.keywords | Induced pluripotent stem cell | |
dc.keywords | Mesenchymal stroma cell | |
dc.keywords | Nuclear reprogramming | |
dc.keywords | OP9 cell line | |
dc.keywords | Stem cell | |
dc.keywords | Stem cell culture | |
dc.keywords | Thawing | |
dc.keywords | Cell differentiation | |
dc.keywords | Hematopoietic stem cell | |
dc.keywords | Immunopathology | |
dc.keywords | Mesenchymal stem cell | |
dc.keywords | metabolism | |
dc.keywords | Humans | |
dc.keywords | Immune system diseases | |
dc.keywords | Induced pluripotent stem cells | |
dc.keywords | Mesenchymal stem cells | |
dc.language | English | |
dc.publisher | Humana Press Inc. | |
dc.source | Methods in Molecular Biology | |
dc.subject | Induced pluripotent stem cells | |
dc.subject | Nuclear reprogramming | |
dc.subject | Cell differentiation | |
dc.title | Generation and hematopoietic differentiation of mesenchymal stromal/stem cell-derived induced pluripotent stem cell lines for disease modeling of hematopoietic and immunological diseases | |
dc.type | Book Chapter | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0002-3158-1587 | |
local.contributor.kuauthor | Esken, Gülen Güney |